Bioorganic and Medicinal Chemistry

SJR Rank #10,165H-index: 198SJR: 0.582Best quartile: Q2APC: US$3,960
Journal website: aims, scope and author guidelines
Publisher

Elsevier Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.150.30.450.6

Subject Categories

  • Drug DiscoveryQ2
  • Organic ChemistryQ2
  • Pharmaceutical ScienceQ2
  • BiochemistryQ3
  • Clinical BiochemistryQ3
  • Molecular BiologyQ3
  • Molecular MedicineQ3

Areas: Biochemistry, Genetics and Molecular Biology · Chemistry · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Synthesis and biological activitySynthesis and Biological EvaluationDiverse Scientific and Economic StudiesChemical Synthesis and AnalysisCancer therapeutics and mechanismsComputational Drug Discovery MethodsClick Chemistry and ApplicationsBioactive Compounds and Antitumor AgentsReceptor Mechanisms and SignalingHuman auditory perception and evaluation

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs02505007501000

Documents per Year

20222025090180270360

Detailed Information

ISSN

1464-3391, 0968-0896

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

3.52

References per Document

56.27

Coverage

1993-2026

Scope

Bioorganic & Medicinal Chemistry publishes complete accounts of research of outstanding significance and timeliness on all aspects of molecular interactions at the interface of chemistry and biology, together with critical review articles. The journal publishes reports of experimental results in medicinal chemistry, chemical biology and drug discovery and design, emphasizing new and emerging advances and concepts in these fields. The aim of the journal is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents. The Journal welcomes papers on: the medicinal chemistry and associated biology (including target identification and validation) of established or new disease targets- the reporting of the discovery, design or optimization of potent new compounds or biological agents- the analysis and discussion of structure-activity relationships and pharmacological issues relevant to drug design and action using in vitro and in vivo models, including the use of computational techniques when closely linked to experimental data- the reporting of "first-in-class" new therapeutic compounds- the chemical biology or bioorganic/bioinorganic chemistry that significantly advances knowledge of a biological mechanism- methodological advances that are chemistry-based and which significantly impact on medicine or biology- the preparation and examination of biotherapeutics for the treatment of pathophysiological disease states- the development of materials for specific therapeutic targeting

Metrics from SCImago Journal Rank 2025. View on SCImago